PeptiDream Inc
TSE:4587
PeptiDream Inc
TSE:4587
Price:
1 184
JPY
-2.23%
Market Closed
Market Cap:
¥153.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PeptiDream Inc
TSE:4587
|
JP |
|
Biotalys NV
XBRU:BTLS
|
BE |
|
H
|
Harn Len Corporation Bhd
KLSE:HARNLEN
|
MY |
|
G
|
Global Digital Solutions Inc
OTC:GDSI
|
US |
|
S
|
SL Corp
KRX:005850
|
KR |
|
G
|
GG Dandekar Machine Works Ltd
BSE:505250
|
IN |
|
G
|
Groupe Okwind SA
PAR:ALOKW
|
FR |
Balance Sheet
Balance Sheet Decomposition
PeptiDream Inc
PeptiDream Inc
Balance Sheet Decomposition is not available for
PeptiDream Inc
PeptiDream Inc
Balance Sheet
PeptiDream Inc
PeptiDream Inc
Currency: JPY
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
6 987
|
7 149
|
11 747
|
5 248
|
19 508
|
48 118
|
28 683
|
|
| Cash Equivalents |
6 987
|
7 149
|
11 747
|
5 248
|
19 508
|
48 118
|
28 683
|
|
| Short-Term Investments |
0
|
0
|
69
|
6
|
6
|
6
|
6
|
|
| Total Receivables |
312
|
7 531
|
822
|
16 589
|
4 971
|
5 283
|
5 890
|
|
| Accounts Receivables |
312
|
5 655
|
811
|
16 589
|
4 971
|
5 283
|
5 867
|
|
| Other Receivables |
0
|
1 875
|
10
|
0
|
0
|
0
|
23
|
|
| Inventory |
341
|
586
|
925
|
2 679
|
2 404
|
2 672
|
3 191
|
|
| Other Current Assets |
399
|
376
|
274
|
551
|
336
|
1 131
|
1 150
|
|
| Total Current Assets |
8 040
|
15 642
|
13 836
|
25 073
|
27 225
|
57 210
|
38 920
|
|
| PP&E Net |
5 735
|
5 767
|
6 437
|
18 125
|
17 358
|
17 526
|
18 929
|
|
| PP&E Gross |
5 735
|
5 767
|
6 437
|
18 125
|
17 358
|
17 526
|
18 929
|
|
| Accumulated Depreciation |
1 641
|
2 174
|
2 765
|
4 514
|
6 635
|
8 550
|
10 209
|
|
| Intangible Assets |
104
|
79
|
76
|
2 233
|
2 211
|
2 143
|
2 017
|
|
| Goodwill |
12
|
0
|
0
|
8 371
|
8 371
|
8 371
|
8 371
|
|
| Note Receivable |
96
|
152
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
3 196
|
4 105
|
6 683
|
6 522
|
11 882
|
2 624
|
2 132
|
|
| Other Long-Term Assets |
636
|
522
|
2
|
3 542
|
2 416
|
4 897
|
6 664
|
|
| Other Assets |
12
|
0
|
0
|
8 371
|
8 371
|
8 371
|
8 371
|
|
| Total Assets |
17 817
N/A
|
26 267
+47%
|
27 035
+3%
|
63 865
+136%
|
69 464
+9%
|
92 770
+34%
|
77 033
-17%
|
|
| Liabilities | ||||||||
| Accounts Payable |
39
|
55
|
101
|
641
|
300
|
352
|
398
|
|
| Short-Term Debt |
0
|
0
|
0
|
500
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2 191
|
2 586
|
2 593
|
17 042
|
|
| Other Current Liabilities |
640
|
4 651
|
1 275
|
7 699
|
5 731
|
15 462
|
5 979
|
|
| Total Current Liabilities |
679
|
4 706
|
1 376
|
11 030
|
8 617
|
18 407
|
23 419
|
|
| Long-Term Debt |
0
|
0
|
0
|
18 358
|
19 634
|
17 042
|
0
|
|
| Deferred Income Tax |
0
|
0
|
308
|
0
|
386
|
0
|
0
|
|
| Other Liabilities |
161
|
344
|
0
|
2 436
|
477
|
559
|
2 086
|
|
| Total Liabilities |
839
N/A
|
5 050
+502%
|
1 684
-67%
|
31 824
+1 789%
|
29 114
-9%
|
36 008
+24%
|
25 505
-29%
|
|
| Equity | ||||||||
| Common Stock |
3 931
|
3 934
|
3 957
|
3 957
|
3 957
|
3 957
|
3 957
|
|
| Retained Earnings |
9 573
|
14 021
|
16 373
|
23 848
|
27 805
|
49 393
|
45 587
|
|
| Additional Paid In Capital |
3 927
|
3 930
|
4 452
|
4 524
|
4 550
|
4 736
|
4 654
|
|
| Unrealized Security Profit/Loss |
41
|
13
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
412
|
655
|
620
|
607
|
1 086
|
1 075
|
1 898
|
|
| Other Equity |
0
|
0
|
1 189
|
319
|
5 123
|
249
|
771
|
|
| Total Equity |
16 978
N/A
|
21 217
+25%
|
25 350
+19%
|
32 041
+26%
|
40 350
+26%
|
56 762
+41%
|
51 528
-9%
|
|
| Total Liabilities & Equity |
17 817
N/A
|
26 267
+47%
|
27 035
+3%
|
63 865
+136%
|
69 464
+9%
|
92 770
+34%
|
77 033
-17%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
125
|
126
|
130
|
130
|
130
|
130
|
129
|
|
Switch to:
Switch to:
See Also
Discover More
